Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions

Neuroscience

Volumn 119, Issue 4, 2003, Pages 1185-1197

  Van Groen, T ^a,b   Liu, L ^a   Ikonen, S ^c   Kadish, I ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid; Limbic system; Mouse; Plaques; Subiculum

Indexed keywords

AMYLOID A PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DEAFFERENTATION; DISEASE MARKER; ENTORHINAL CORTEX; EXPERIMENTAL MODEL; HIPPOCAMPUS; MOUSE; NERVE FIBER TRANSPORT; NONHUMAN; PRIORITY JOURNAL; SUBICULUM; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

EID: 0037756809     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00215-X     Document Type: Article

References (70)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging. 21:2000;383-421.
2. Arelin K., Kinoshita A., Whelan C.M., Irizarry M.C., Rebeck G.W., Strickland D.K., Hyman B.T. LRP and senile plaques in Alzheimer's disease colocalization with apolipoprotein E and with activated astrocytes . Mol Brain Res. 104:2002;38-46.
3. Bondolfi L., Calhoun M., Ermini F., Kuhn H.G., Wiederhold K.-H., Walker L., Staufenbiel M., Jucker M. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J Neurosci. 22:2002;515-522.
4. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.-M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
5. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1993;239-259.
6. Braak H., Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm. 53:1998;127-140.
7. Braak H., Braak E. Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol. 81:1991;261-268.
8. Bussière T., Friend P.D., Sadeghi N., Wicinski B., Lin G.I., Bouras C., Giannakopoulos P., Robakis N.K., Morrison J.H., Perl D.P., Hof P.R. Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience. 112:2002;75-91.
9. Buxbaum J.D., Thinakaran G., Koliatsos V., O'Callahan J., Slunt H.H., Price D.L., Sisodia S.S. Alzheimer amyloid precursor protein in the rat hippocampus transport and processing through the perforant path . J Neurosci. 18:1998;9629-9637.
10. Chen K.S., Soriano F., Lyn W., Grajeda H., Masliah E., Games D. Effects of entorhinal lesions on hippocampal β-amyloid deposition in PDAPP transgenic mice. Soc Neurosci Abs. 24:1998;1502.
11. Cotman C.W., Anderson K.J. Synaptic plasticity and functional stabilization in the hippocampal formation possible role in Alzheimer's disease . Adv Neurol. 47:1988;313-335.
12. Czech C., Delaere P., Macq A.F., Reibaud M., Dreisler S., Touchet N., Schombert B., Mazadier M., Mercken L., Theisen M., Pradier L., Octave J.N., Beyreuther K., Tremp G. Proteolytical processing of mutated human amyloid precursor protein in transgenic mice. Mol Brain Res. 47:1997;108-116.
13. De Lacoste M.-C., White C.L. III. The role of cortical connectivity in Alzheimer's disease pathogenesis a review and model system . Neurobiol Aging. 14:1993;1-16.
14. Delaère P., Duyckaerts C., He Y., Piette F., Hauw J.J. Subtypes and differential laminar distributions of βA4 deposits in Alzheimer's disease relationship with the intellectual status of 26 cases . Acta Neuropathol. 81:1991;328-335.
15. Dickson T.C., Vickers J.C. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience. 105:2001;99-107.
16. Duyckaerts C., Colle M.A., Seilhaen D., Hauw J.J. Laminar spongiosis of the dentate gyrus a sign of disconnection, present in cases of severe Alzheimer's disease . Acta Neuropathol. 95:1998;413-420.
17. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., Hebert L.E., Hennekens C.H., Taylor J.O. Prevalence of Alzheimer's disease in a community population of older persons higher than previously reported . J Am Med Assoc. 262:1989;2551-2556.
18. Fishman C.E., Cummins D.J., Bales K.R., DeLong C.A., Esterman M.A., Hanson J.C., White S.L., Paul S.M., Jordan W.H. Statistical aspects of quantitative image analysis of beta-amyloid in the APP(V717F) transgenic mouse model of Alzheimer's disease. J Neurosci Methods. 30:2001;145-152.
19. Fukumoto H., Asami-Odaka A., Suzuki N., Shimada H., Ihara Y., Iwatsubo T. Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer's disease predominance of A beta 42(43) and association of A beta 40 with cored plaques . Am J Pathol. 148:1996;259-265.
20. Garvey W., Fathi A., Bigelow F., Jiminez C.L., Carpenter B.T. Rapid, reliable and economical silver stain for neurofibrillary tangles and senile plaques. J Histotechnol. 14:1991;39-42.
21. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., Relkin N.R. Intraneuronal Abeta42 accumulation in human brain. Am J Pathol. 156:2000;15-20.
22. Greenfield J.P., Gross R.S., Gouras G.K., Xu H. Cellular and molecular basis of β-amyloid precursor protein metabolism. Frontiers Biosci. 5:2000;72-83.
23. Haass C., De Strooper B. The presenilins in Alzheimer's disease proteolysis holds the key . Science. 286:1999;916-919.
24. Hardy J. An 'anatomical cascade hypothesis' for Alzheimer's disease. Trends Neurosci. 15:1992;200-201.
25. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
26. Hyman B.T., Van Hoesen G.W., Kromer L.J., Damasio A.R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol. 20:1986;472-481.
27. Hyman B.T., Kromer L.J., Van Hoesen G.W. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease. Ann Neurol. 21:1987;259-267.
28. Hyman B.T., Kromer L.J., Van Hoesen G.W. A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50. Brain Res. 450:1988;392-397.
29. Ida N., Hartmann T., Pantel J., Schroder J., Zerfass R., Forstl H., Sandbrink R., Masters C.L., Beyreuther K. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem. 271:1996;22908-22914.
30. Ikeda S.I., Allsop D., Glenner G.G. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. Lab Invest. 60:1989;113-122.
31. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals evidence that an initially deposited species is A beta 42(43) . Neuron. 13:1994;45-53.
32. Iwatsubo T., Saido T.C., Mann D.M., Lee V.M., Trojanowski J.Q. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am J Pathol. 149:1996;1823-1830.
33. Janciauskiene S., Sun Y.-X., Wright H.T. Interactions of Aβ with endogenous anti-inflammatory agents a basis for chronic neuroinflammation in Alzheimer's disease . Neurobiol Dis. 10:2002;187-200.
34. Janus C., Westaway D. Transgenic mouse models of Alzheimer's disease. Physiol Behav. 73:2001;873-886.
35. Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., Khan K., Gordon M., Tan H., Games D., Lieberburg I., Schenk D., Seubert P., McConlogue L. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA. 94:1997;1550-1555.
36. Kadish I., van Groen T. Enormous amount of amyloidβ deposits does not affect entorhinal cortex lesion-induced sprouting in the hippocampus in AD mutant mice. Soc Neurosci Abstr. 27:2001;860 .20.
37. Kadish I., Pradier L., van Groen T. Transgenic mice expressing the human presenilin 1 gene demonstrate enhanced hippocampal reorganization following entorhinal cortex lesions. Brain Res Bull. 57:2002;587-594.
38. Kamal A., Stokin G.B., Yang Z., Xia C.H., Goldstein L.S. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron. 28:2000;449-459.
39. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature. 414:2001;643-648.
40. Koo E.H., Sisodia S.S., Archer D.R., Martin L.J., Weidemann A., Beyreuther K., Fischer P., Masters C.L., Price D.L. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA. 87:1990;1561-1565.
41. Lazarov O., Lee M., Peterson D.A., Sisodia S.S. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci. 22:2002;9785-9793.
42. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu Rev Neurosci. 24:2001;1121-1159.
43. Liu L., Ikonen S., Heikkinen T., Tapiola T., van Groen T., Tanila H. The effects of long-term treatment with Metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice. Exp Neurol. 173:2002;196-204.
44. McGowan E., Sanders S., Iwatsubo T., Takeuchi A., Saido T., Zehr C., Yu X., Uljon S., Wang R., Mann D., Dickson D., Duff K. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol Dis. 6:1999;231-244.
45. Mizutani T., Kasahara M. Hippocampal atrophy secondary to entorhinal cortical degeneration in Alzheimer-type dementia. Neurosci Lett. 222:1997;119-122.
46. Morris J., Storandt M., McKeel D., Rubin E., Price J., Grant E., Berg L. Cerebral amyloid deposition and diffuse plaques in normal aging evidence for presymptomatic and very mild Alzheimer's disease . Neurology. 46:1996;707-719.
47. Morrison J.H., Hof P.R. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res. 136:2002;467-486.
48. O'Mara S.M., Commins S., Anderson M., Gigg J. The subiculum a review of form, physiology and function . Prog Neurobiol. 64:2001;129-155.
49. Price D.L., Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci. 21:1998;479-505.
50. Puoliväli J., Wang J., Heikkinen T., Heikkila M., Tapiola T., van Groen T., Tanila H. Hippocampal Abeta42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol Dis. 9:2002;339-347.
51. Rogers J., Lue L.F. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem Int. 39:2001;333-340.
52. Saper C.B., Wainer B.H., German D.C. Axonal and transneuronal transport in the transmission of neurological disease potential role in system degenerations, including Alzheimer's disease . Neuroscience. 23:1987;389-398.
53. Seabrook G.R., Rosahl T.W. Transgenic animals relevant to Alzheimer's disease. Neuropharmacology. 38:1999;1-17.
54. Selkoe D.J. Alzheimer's disease genes, proteins, and therapy . Physiol Rev. 81:2001;741-766.
55. Sheng J.G., Price D.L., Koliatsos V.E. Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis. J Neurosci. 22:2002;9794-9799.
56. Stalder M., Deller T., Staufenbiel M., Jucker M. 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice no evidence of intracellular amyloid . Neurobiol Aging. 22:2001;427-434.
57. Storey E., Cappai R. The amyloid precursor protein of Alzheimer's disease and the Aβ peptide. Neuropathol Applied Neurobiol. 25:1999;81-97.
58. Su Y., Ni B. Selective deposition of amyloid-β protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease. J Neurosci Res. 53:1998;177-186.
59. van Groen T., Wyss J.M. Projections from the laterodorsal nucleus of the thalamus to the limbic and visual cortices in the rat. J Comp Neurol. 324:1992;427-448.
60. van Groen T., Kadish I. Changes in amyloid pathology during aging in APP/PS1 mutant mice. Soc Neurosci Abstr. 27:2001;860 .11.
61. van Groen T., Miettinen P., Kadish I. The entorhinal cortex of the mouse organization of the projection to the hippocampal formation . Hippocampus. 13:2003;133-149.
62. Weidemann A., Eggert S., Reinhard F.B., Vogel M., Paliga K., Baier G., Masters C.L., Beyreuther K., Evin G. A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with notch processing. Biochemistry. 41:2002;2825-2835.
63. White F., Nicoll J.A., Horsburgh K. Alterations in ApoE and ApoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion. Exp Neurol. 169:2001;307-318.
64. Wisniewski H.M., Bancher C., Barcikowska M., Wen G.Y., Curry J. Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol. 78:1989;337-347.
65. Wisniewski H.M., Sadowski M., Jakubowska-Sdowska K., Tarnawski M., Wegiel J. Diffuse, lake-like amyloid-β deposits in the parvopyramidal layer of the presubiculum in Alzheimer's disease. J Neuropathol Exp Neurol. 57:1998;674-683.
66. Wyss J.M., van Groen T. Connections between the retrosplenial cortex and the hippocampal formation in the rat. Hippocampus. 2:1992;1-12.
67. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease a double-edged sword . Neuron. 35:2002;419-432.
68. Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., Masliah E., Mucke L. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med. 7:2001;612-618.
69. Wyss-Coray T., Yan F., Lin A.H., Lambris J.D., Alexander J.J., Quigg R.J., Masliah E. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci USA. 99:2002;10837-10842.
70. Yamaguchi H., Hirai S., Morimatsu M., Shoji M., Ihara Y. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining. Acta Neuropathol. 76:1988;541-549.